ALMR vs NEOG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ALMR · Alamar Biosciences$28.05 ▲ 4.26%
NEOG · Neogen$11.76 ▲ 0.68%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ALMR +27.5%
- NEOG +23.7%
Head to head
| Metric | ALMR | NEOG |
|---|---|---|
| Price | $28.05 | $11.76 |
| Change today | ▲ 4.26% | ▲ 0.68% |
| Market cap | $1.95B | $2.57B |
| Return, 3 months | +0.2% | +3.2% |
| Return, year to date | – | +68.2% |
| Return, 1 year | – | +83.7% |
| P/E (TTM) | – | – |
| P/B | 6.4 | 1.2 |
| P/E percentile vs own 5y | 43rd | 34th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +82.1% | +6.5% |
| Net profit growth (YoY) | -87.9% | -132.8% |
| Gross margin | 58.7% | 47.4% |
| Operating margin | -40.6% | -0.8% |
| Net margin | -49.5% | -6.3% |
| Return on equity | -15.9% | -2.7% |
| Analyst target vs. price | +16.5% | +19.0% |
| Analyst buy share | 67% | 67% |
| RSI (14) | 46 | 45 |
| 30-day volatility | 115.2% | 52.7% |
| Max drawdown, 1 year | -38.3% | -27.7% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NEOG is the largest of the group by market value.
- ALMR is growing revenue fastest.
- NEOG keeps the most profit per dollar of sales.
- NEOG has been the calmest stock over the last 30 days.